He Jun-Yan相关文献与解析，生知库 | 链接生命科学的每一步

Integrative analysis of EMT-driving genes identifies a prognostic signature and GJB2 as a potential biomarker in glioblastoma

对EMT驱动基因的整合分析鉴定出一种预后特征，并将GJB2作为胶质母细胞瘤的潜在生物标志物。

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2025.1754988

Liu, Xiao-Fei; Wang, Bing; Zhou, Min; Gong, Duo; Zhang, Jia-Hui; He, Jun-Yan; Xiao, Wen-Tao

细胞生物学

发表日期：2025

文献求助收藏

CRISPR-Cas9 screening identifies a gene signature predictive of prognosis in glioblastoma

CRISPR-Cas9筛选鉴定出可预测胶质母细胞瘤预后的基因特征

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-07815-8

Ren, Xing; Yao, Xiang-Rong; Chen, Kun; Xiao, Wen-Tao; He, Jun-Yan

细胞生物学

发表日期：2025

文献求助收藏

Elevated POSTN expression predicts poor prognosis and is associated with radioresistance in cervical cancer patients treated with radical radiotherapy.

POSTN 表达升高预示着预后不良，并且与接受根治性放射治疗的宫颈癌患者的放射抗性相关

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-88908-2

Huang Cui-Qin, Xiao Wen-Tao, Yao Xiang-Rong, Li Zhi-Min, He Jun-Yan

肿瘤

发表日期：2025

文献求助收藏

ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration.

ADORA2B 促进头颈部鳞状细胞癌的增殖和迁移，并与免疫浸润有关

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-025-14102-2

Li Pian, Pang Ke-Ling, Chen Shuang-Jing, Yang Dong, Nai Ai-Tao, He Gui-Cheng, Fang Zhe, Yang Qiao, Cai Man-Bo, He Jun-Yan

Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC.

基于 CRISPR-Cas9 筛选破译增殖必需基因特征，以预测 HNSCC 的预后并表征其免疫微环境

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-025-14181-1

Pang Ke-Ling, Li Pian, Yao Xiang-Rong, Xiao Wen-Tao, Ren Xing, He Jun-Yan

其它

发表日期：2025

文献求助收藏

C16orf74 is a novel prognostic biomarker and associates with immune infiltration in head and neck squamous cell carcinoma

C16orf74是一种新型预后生物标志物，与头颈部鳞状细胞癌的免疫浸润相关。

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0322701

Yao, Xiang-Rong; Xiao, Fang-Zhu; Xiao, Wen-Tao; Huang, Cui-Qin; He, Jun-Yan

Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database

基于TCGA数据库的宫颈癌根治性放疗患者预后预测模型的建立与验证

期刊:Translational Cancer Research

影响因子:1.7

doi:10.21037/tcr-23-1772

He, Jun-Yan; Li, Zhi-Min; Chen, Ya-Ting; Zhao, Bi-Huan; Yu, Chang

Integrative analysis of a novel snoRNA-based prognostic signature in patients with breast cancer

对一种新型基于snoRNA的乳腺癌患者预后特征进行整合分析

Aberrant outputs of glutamatergic neurons in deep cerebellar nuclei mediate dystonic movements.

小脑深部核团谷氨酸能神经元的异常输出介导肌张力障碍运动

Effect of Pulsed Electric Field Pretreatment on the Texture and Flavor of Air-Dried Duck Meat

脉冲电场预处理对风干鸭肉质地和风味的影响

Integrative analysis of EMT-driving genes identifies a prognostic signature and GJB2 as a potential biomarker in glioblastoma

对EMT驱动基因的整合分析鉴定出一种预后特征，并将GJB2作为胶质母细胞瘤的潜在生物标志物。

CRISPR-Cas9 screening identifies a gene signature predictive of prognosis in glioblastoma

CRISPR-Cas9筛选鉴定出可预测胶质母细胞瘤预后的基因特征

Elevated POSTN expression predicts poor prognosis and is associated with radioresistance in cervical cancer patients treated with radical radiotherapy.

POSTN 表达升高预示着预后不良，并且与接受根治性放射治疗的宫颈癌患者的放射抗性相关

ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration.

ADORA2B 促进头颈部鳞状细胞癌的增殖和迁移，并与免疫浸润有关

Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC.

基于 CRISPR-Cas9 筛选破译增殖必需基因特征，以预测 HNSCC 的预后并表征其免疫微环境

C16orf74 is a novel prognostic biomarker and associates with immune infiltration in head and neck squamous cell carcinoma

C16orf74是一种新型预后生物标志物，与头颈部鳞状细胞癌的免疫浸润相关。

Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database

基于TCGA数据库的宫颈癌根治性放疗患者预后预测模型的建立与验证